Orchidectomy (orx) of rats increases bone metabolism, the activity of osteoclasts more than of osteoblasts which results in osteoporosis. As testosterone (T) may be metabolized to estrogens, the effects of a 3-month treatment of orx rats with an aqueous/ethanolic extract of black cohosh (Cimicifuga racemosa = CR) T, estradiol-17β (E2) on density of cortical and cancellous structures of the proximal tibia was determined. The CR preparation was tested, because it contains unidentified substances which appear also to be antiosteoporotic.
Bone density of the metaphysis of the tibia was measured by quantitative computer tomography. Stability of the tibia and expression of osteoblast- and osteoclast-specific genes in the metaphysis of the tibia were also studied.
Cancellous density but not the total area of the cancellous metaphysis was significantly reduced in control animals and this effect could in part be prevented by E2, T and the CR extract. Cortical parameters were unaffected by T and the CR extract while E2 reduced the total cortical area. The mechanical stability was highest in the E2- and CR and low in orx and T-treated animals. Gene expression of osteocalcin, TGFβ1 and tartrate-resistant acid phosphatase was reduced by E2 and the CR extract whereas T treatment increased these parameters. Since orx results in increased bodyweight, the sizes of two fat depots as well as serum leptin concentrations were also determined. E2 and the CR extract but not T prevented the orx-induced fat accumulation largely, resulting in reduced leptin concentrations.
It is concluded that the effects of E2 and T in the bone and in fat tissue are dissimilar in that only E2 extract but not T increase bone stability and decrease fat accumulation. The CR extract BNO 1055 had mild antiosteoporotic and lipolytic or antilipotropic effects which may make these extracts useful to prevent osteoporosis in males.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Maturitas
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
- Pharmacology of Cimicifuga racemosa extract BNO 1055 in rats: bone, fat and uterus.Maturitas. 2003; 44: S39-S50
- Direct effects of sex steroid hormones on adipose tissues and obesity.Obes Rev. 2004; 5: 197-216
- Steroid hormone receptor expression and action in bone.Clin Sci (Lond). 2000; 98: 217-240
- Evidence for selective estrogen receptor modulator activity in a black cohosh (Cimicifuga racemosa) extract: comparison with estradiol-17beta.Eur J Endocrinol. 2003; 149: 351-362
- Effects of estradiol-17β, testosterone and a black cohosh preparation on bone and prostate in orchidectomized rats.Maturitas. 2005; 51: 177-186
- Fluctuation of serum leptin level in rats after ovariectomy and the influence of estrogen supplement.Life Sci. 1999; 64: 2299-2306
- Two different pathways for the maintenance of trabecular bone in adult male mice.J Bone Miner Res. 2002; 17: 555-562
- Aromatase in bone: roles of Vitamin D3 and androgens.J Steroid Biochem Mol Biol. 2003; 86: 393-397
- The multifaceted mechanisms of estradiol and estrogen receptor signaling.J Biol Chem. 2001; 276: 36869-36872
- Sex- and age-related response to aromatase deficiency in bone.Biochem Biophys Res Commun. 2001; 280: 1062-1068
- Mechanisms of sex steroid effects on bone.Biochem Biophys Res Commun. 2005; 328: 688-696
- Standardized bending and breaking test for the normal and osteoporotic metaphyseal tibias of the rat: effect of estradiol, testosterone, and raloxifene.J Bone Miner Res. 2006; 21: 89-96
- Effect of estrogen and tail-suspension on expression of osteocalcin mRNA in femur of ovariectomized rats.Environ Med. 2000; 44: 82-84
- The actions and interactions of sex steroids and growth factors/cytokines on the skeleton.Mol Endocrinol. 1999; 13: 819-828
- Application of automatic image segmentation to tibiae and vertebrae from ovariectomized rats.Bone. 1997; 21: 401-409
- Cloning, sequence, and developmental expression of a type 5, tartrate-resistant, acid phosphatase of rat bone.J Biol Chem. 1991; 266: 24684-24689
- Expression of estrogen receptors and enzymes involved in sex steroid metabolism in the rat tibia during sexual maturation.J Endocrinol. 2004; 180: 457-467
- The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers.Maturitas. 2003; 44: S67-S77
- Aromatase activity and bone homeostasis in men.J Clin Endocrinol Metab. 2004; 89: 5898-5907
- Effect of estrogen deficiency in the male: the ArKO mouse model.Mol Cell Endocrinol. 2002; 193: 7-12
- Androgens and the skeleton.Minerva Endocrinol. 2005; 30: 15-25
- Elucidation of estrogen receptor function in bone with the use of mouse models.Trends Endocrinol Metab. 2002; 13: 195-200
- Effects of the steroidal aromatase inhibitor exemestane and the nonsteroidal aromatase inhibitor letrozole on bone and lipid metabolism in ovariectomized rats.Clin Cancer Res. 2004; 10: 5717-5723
- Sex steroid metabolism in the tibial growth plate of the rat.Endocrinology. 2002; 143: 4048-4055
- The steroidal aromatase inhibitor exemestane prevents bone loss in ovariectomized rats.Bone. 2004; 34: 384-392
- Targeted overexpression of androgen receptor in osteoblasts: unexpected complex bone phenotype in growing animals.Endocrinology. 2004; 145: 3507-3522
- In vitro effects of the Cimicifuga racemosa extract BNO.Maturitas. 2003; 44: S31-S38
- Cimicifuga racemosa extract BNO 1055 inhibits proliferation of the human prostate cancer cell line LNCaP.Phytomedicine. 2005; 12: 178-182
- Inhibitory aryl hydrocarbon receptor-estrogen receptor alpha cross-talk and mechanisms of action.Chem Res Toxicol. 2003; 16: 807-816
Published online: July 18, 2006
© 2006 Elsevier Ireland Ltd. Published by Elsevier Inc. All rights reserved.